Eltrombopag olamine and Autoimmune disorder - a phase IV clinical study of FDA data

Summary:

Autoimmune disorder is reported as a side effect among people who take Eltrombopag olamine (eltrombopag olamine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclosporine, and have Lymphoma.

The phase IV clinical study analyzes which people have Autoimmune disorder when taking Eltrombopag olamine. It is created by eHealthMe based on reports of 3,901 people who have side effects when taking Eltrombopag olamine from the FDA, and is updated regularly.

What is Eltrombopag olamine?

Eltrombopag olamine has active ingredients of eltrombopag olamine. eHealthMe is studying from 3,901 Eltrombopag olamine users. Check the latest studies of Eltrombopag olamine.

What is Autoimmune disorder?

Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue) is found to be associated with 720 drugs and 822 conditions by eHealthMe. Check the latest studies of Autoimmune disorder.

On Jul, 10, 2026

3,901 people reported to have side effects when taking Eltrombopag olamine.
Among them, 11 people (0.28%) have Autoimmune disorder.

Could Eltrombopag olamine cause Autoimmune disorder?

Among these 11 people:

How long have people been on Eltrombopag olamine when they have Autoimmune disorder? *

What is the gender of people who have Autoimmune disorder when taking Eltrombopag olamine? *

female: 0.0 %
male: 100 %

What is the age of people who have Autoimmune disorder when taking Eltrombopag olamine? *

What are other drugs people take besides Eltrombopag olamine? *

Cyclosporine: 4 people, 36.36%

What are other side effects people have besides Autoimmune disorder? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 81.82%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 9 people, 81.82%
Myelosuppression (a decrease in the production of blood cells): 9 people, 81.82%
Head Injury: 9 people, 81.82%
Bleeding Into The Skin: 9 people, 81.82%
Aplastic Anemia: 8 people, 72.73%
Lymphoma (cancer that begins in immune system cells): 7 people, 63.64%
Drug Ineffective: 7 people, 63.64%
Anaemia (lack of blood): 3 people, 27.27%
Leukopenia (less number of white blood cells in blood): 1 person, 9.09%

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 81.82%
Lymphoma (cancer that begins in immune system cells): 9 people, 81.82%
Aplastic Anemia: 6 people, 54.55%
Leukopenia (less number of white blood cells in blood): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Eltrombopag olamine and have Autoimmune disorder?

- Check whether Autoimmune disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eltrombopag olamine:

Eltrombopag olamine (3,901 reports)

Browse all side effects of Eltrombopag olamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Autoimmune disorder:

Autoimmune disorder (720 drugs)

Browse all the conditions that are associated with Autoimmune disorder:

Autoimmune disorder (822 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eltrombopag olamine (the active ingredients of Eltrombopag olamine) and Eltrombopag olamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.